Trial
NCT04378075
A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
PTC Therapeutics
Collaborators
—
Condition
Mitochondrial Diseases
Intervention
Vatiquinone
Why stopped
Sponsor decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-31